Hers vs TMates: Wegovy brand vs compounded semaglutide options
Hers vs TMates is a choice between FDA-approved brand medication and compounded semaglutide. Quick verdict: pick Hers for brand-name Wegovy® and no compounded drugs; pick TMates for a flat-rate compounded semaglutide plan with 24/7 U.S. doctor access.
How Hers and TMates differ at a glance
This comparison focuses on the most distinctive differences supported by source evidence: medication type and regulatory status, pricing and billing structure, clinician access and check-ins, state availability and membership or coverage rules, and formulation sourcing.
Medication type and regulatory status
Hers offers FDA-approved brand-name Wegovy® (semaglutide), explicitly stating no compounded medications. TMates provides clinically dosed compounded semaglutide, noting that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. That regulatory distinction is central: Hers markets an FDA-approved finished product while TMates offers a compounded product using the same active ingredient.
Learn about Hers FDA-approved Wegovy®
Pricing model and billing details
Hers lists Wegovy® pill from $149/mo and injectable from $199/mo, but also notes that an active Hers Weight Loss Membership is required ($39 first month, auto-renews at $149/month thereafter) and that total cost includes membership and medication billed separately. TMates advertises a flat $199/month at every dose with no step-up fees and free shipping for semaglutide. TMates also presents multi-month pricing tiers on its landing evidence but emphasizes the flat-rate message across doses.
Clinician access and ongoing oversight
Hers highlights a personalized care team with ongoing dose check-ins. TMates emphasizes 24/7 access to U.S.-based doctors and virtual check-in appointments for ongoing medical oversight, presenting actual physician availability rather than messaging-only support. Both describe clinician supervision, but TMates specifically promises round-the-clock U.S. doctor access in all 50 states.
Explore TMates semaglutide plan
State availability and eligibility notes
Hers states that treatment is not available in all 50 states and that prescriptions require clinician determination of medical appropriateness. TMates claims licensed coverage in all 50 states and that availability is based on medical eligibility. Each provider ties access to clinician review and state rules, with TMates asserting nationwide licensed coverage and Hers noting limits in some states.
Formulation and sourcing differences
Hers sells name brand Wegovy® and stresses it is not a compounded product. TMates notes its medications are formulated in U.S.-based facilities and describes its semaglutide as compounded, highlighting flexibility in dosage. TMates contrasts compounded semaglutide with Wegovy or Zepbound by saying they work through the same mechanism but compounded semaglutide offers more dosage flexibility and access at a lower price point.
Comparison table: Hers vs TMates
| Criteria | Hers | TMates |
|---|---|---|
| Medication type | FDA-approved Wegovy®, not compounded | Clinically dosed compounded semaglutide |
| Starting price | Wegovy® pill from $149/mo; injectable from $199/mo | $199/month flat at every dose |
| Membership or fees | Active membership required; $39 first month, auto-renews at $149/mo | Direct-pay flat model; free shipping noted |
| Clinician access | Personalized care team with ongoing dose check-ins | 24/7 U.S. doctor access and virtual check-ins |
| State availability | Not available in all 50 states; prescription required | Licensed coverage in all 50 states; availability based on eligibility |
| Regulatory note | Name brand, FDA-approved product | Compounded medication not FDA-approved |
What the evidence does not supply
Source information does not provide direct comparative data on efficacy outcomes, specific side effect rates, or guarantee of prescription. Insurance billing details for Hers beyond membership language and the exact states where Hers is unavailable are not supplied in the captured evidence. TMates’ public detail on tirzepatide availability is limited in the source evidence.
Final comparison and recommendation: Hers vs TMates
Use the primary keyword when deciding: Hers vs TMates boils down to brand-name FDA approval and membership requirements versus a compounded, flat-rate program with 24/7 U.S. doctor access. Choose Hers if you prioritize an FDA-approved Wegovy® product and want to avoid compounded medications. Choose TMates if you prefer a flat $199/month compounded semaglutide program with consistent physician availability across all 50 states.